INDIANAPOLIS, Sept. 9, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today presented data from the LIBRETTO-001 clinical trial intended to support the registration of oral selpercatinib[1] monotherapy, also known as LOXO-292, for the treatment of RET fusion-positive non-small cell lung cancer (NSCLC). In the registration dataset consisting of t

CARLSBAD, Calif., Sept. 9, 2019 /PRNewswire/ -- Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food and Drug Administration-approved, next-generation sequencing-based Oncomine Dx Target Test to identify certain non-small cell lung cancer (NSCLC) and thyroid cancer patients w

AMSTERDAM, Sept. 9, 2019 /PRNewswire/ -- SpePharm AG, a subsidiary of Norgine B.V., announced that the United States District Court for the District of Delaware ruled on 4th September 2019 in favour of SpePharm in its proceeding against Eisai Inc., upholding SpePharm's licensed rights for SALAGEN®

SAN JOSE, Calif., Sept. 8, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that Vu Truong, Ph.D., Chief Executive Officer, will present at the H.

WALTHAM, Mass., Sept. 8, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) — the nation's leading renal care company – and the

THOUSAND OAKS, Calif., Sept. 8, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors. AMG 510 is a first-in-class investigational oral therapy that is designed to selectively and irreversibly target the KRASG12C protein.

TAIPEI, Sept. 7, 2019 /PRNewswire/ -- Supported by the idea of garnering global wisdom to improve the healthcare system in China, Wuxi Municipal Government, Wuxi High-tech District, and AstraZeneca, as a founding partner, officially inaugurated Wuxi International Life Science Innovation Park on September 7, 2019

GUANGZHOU, China, Sept. 7, 2019 /PRNewswire/ -- The award-winning American Chamber of Commerce in South China (AmCham South China) delegation, led by Chamber's President Dr. Harley Seyedin, arrived in Xiamen yesterday to attend the China International Fair for Investment and

KENT, Wash., Sept. 6, 2019 /PRNewswire/ -- After more than 10 years of planning and community partnership, the YMCA of Greater Seattle is excited to announce the grand opening of its newest facility, the Kent YMCA (10828 SE 248th St., Kent, WA 98030). A grand opening celebration will take place

NASHVILLE, Tenn., Sept. 6, 2019 /PRNewswire/ -- On July 3, 2019, Alive Hospice undertook a mailing of notification letters to individuals potentially affected by a recent data privacy incident.  On or about July 9, 2019, Alive learned that an error occurred in the address export process for the mailing whic